CVRX
CVRx Inc
NASDAQ: CVRX · HEALTHCARE · MEDICAL DEVICES
$7.51
+9.32% today
Updated 2026-04-30
Market cap
$209.97M
P/E ratio
—
P/S ratio
3.71x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$4 – $11
Volume
0.3M
CVRx Inc (CVRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.26M | $6.05M | $13.04M | $22.47M | $39.30M | $51.29M | $56.65M |
| Revenue growth (YoY) | — | -3.3% | +115.4% | +72.4% | +74.9% | +30.5% | +10.4% |
| Cost of revenue | $1.68M | $1.44M | $3.64M | $5.00M | $6.26M | $8.33M | $8.31M |
| Gross profit | $4.57M | $4.61M | $9.40M | $17.47M | $33.04M | $42.96M | $48.34M |
| Gross margin | 73.1% | 76.2% | 72.1% | 77.8% | 84.1% | 83.8% | 85.3% |
| R&D | $8.66M | $6.41M | $7.50M | $9.95M | $11.63M | $11.13M | $11.13M |
| SG&A | $6.11M | $9.72M | $27.86M | $50.05M | $61.60M | $91.32M | $88.47M |
| Operating income | $-10.19M | $-11.51M | $-25.97M | $-42.53M | $-43.10M | $-59.49M | $-51.27M |
| Operating margin | -162.9% | -190.2% | -199.2% | -189.3% | -109.7% | -116.0% | -90.5% |
| EBITDA | $-12.78M | $-11.48M | $-40.60M | $-40.74M | $-43.10M | $-54.89M | $-51.27M |
| EBITDA margin | -204.3% | -189.6% | -311.4% | -181.3% | -109.7% | -107.0% | -90.5% |
| EBIT | $-12.84M | $-11.55M | $-40.77M | $-41.15M | $-43.10M | $-55.51M | — |
| Interest expense | $1.72M | $2.47M | $2.22M | $165000.00 | $1.80M | $4.40M | $5.83M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-14.63M | $-14.11M | $-43.08M | $-41.43M | $-41.20M | $-59.97M | $-53.31M |
| Net income growth (YoY) | — | +3.6% | -205.3% | +3.8% | +0.6% | -45.5% | +11.1% |
| Profit margin | -233.9% | -233.1% | -330.5% | -184.4% | -104.8% | -116.9% | -94.1% |